These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17028465)

  • 1. Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer?
    Granato AM; Frassineti GL; Giovannini N; Ballardini M; Nanni O; Maltoni R; Amadori D; Volpi A
    Tumour Biol; 2006; 27(6):302-8. PubMed ID: 17028465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
    Granato AM; Nanni O; Falcini F; Folli S; Mosconi G; De Paola F; Medri L; Amadori D; Volpi A
    Breast Cancer Res; 2004; 6(1):R38-45. PubMed ID: 14680499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.
    Linderholm BK; Lidbrink E; Tallroth E; Einbeigi Z; Svensson H; von Wachenfeldt A; Norberg B; Carlsson L; Olsson ME; Bergh J; Wilking N; Hatschek T
    Breast; 2013 Dec; 22(6):1142-7. PubMed ID: 23968864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma.
    Brennecke S; Deichmann M; Naeher H; Kurzen H
    Melanoma Res; 2005 Dec; 15(6):515-22. PubMed ID: 16314737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor-alpha, basic fibroblast growth factor and copper as angiogenic markers in premenopausal breast cancer patients: a case-control study.
    Hewala TI; Abd El-Moneim NA; Ebied SA; Sheta MI; Soliman K; Abu-Elenean A
    Br J Biomed Sci; 2010; 67(4):167-76. PubMed ID: 21294443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
    Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
    Sasaki H; Yukiue H; Kobayashi Y; Nakashima Y; Moriyama S; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    Surg Today; 2001; 31(11):1038-40. PubMed ID: 11766079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic peptides in prostatic disease.
    Walsh K; Sherwood RA; Dew TK; Mulvin D
    BJU Int; 1999 Dec; 84(9):1081-3. PubMed ID: 10571640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
    Fuksiewicz M; Kowalska M; Kotowicz B; Rubach M; Chechlinska M; Pienkowski T; Kaminska J
    Clin Chem Lab Med; 2010 Oct; 48(10):1481-6. PubMed ID: 20578967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients.
    Porta C; Paglino C; Imarisio I; Ganini C; Sacchi L; Quaglini S; Giunta V; De Amici M
    Oncology; 2013; 84(2):115-22. PubMed ID: 23154434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
    Curigliano G; Petit JY; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
    Breast Cancer Res Treat; 2005 Sep; 93(1):35-40. PubMed ID: 16184456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patients.
    Pichon MF; Moulin G; Pallud C; Pecking A; Floiras JL
    Anticancer Res; 2000; 20(2B):1189-94. PubMed ID: 10810420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of serum angiogenesis in patients with chronic mountain sickness].
    Yan JH; Li ZQ; Ji LH; Chai KX; Ge RL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Nov; 25(4):457-60. PubMed ID: 21158030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
    Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
    Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.